According to Redhill Biopharma's latest financial reports and stock price the company's current number of shares outstanding is 2,512,050. At the end of 2023 the company had 2,512,050 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 2.51 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Sanofi SNY | 2,507,200,000 | 99,706.93% | ๐ซ๐ท France |
Merck MRK | 2,554,166,667 | 101,576.59% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 2,028,000,000 | 80,630.88% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 44,524.91% | ๐ฎ๐ฑ Israel |
Taro Pharmaceutical TARO | 37,584,891 | 1,396.18% | ๐ฎ๐ฑ Israel |